Atrial fibrillation

Gregory Lip; Laurent Fauchier; S Ben Freedman; Isabelle van Gelder; Andrea Natale; Carola Gianni; Stanley Nattel; Tatjana S. Potpara; Michel Rienstra; Hung Fat Tse; Deirdre A Lane

doi:10.1038/nrdp.2016.16

Atrial fibrillation

Gregory Lip, Laurent Fauchier, S Ben Freedman, Isabelle van Gelder, Andrea Natale, Carola Gianni, Stanley Nattel, Tatjana S. Potpara, Michel Rienstra, Hung Fat Tse, Deirdre A Lane

Cardiovascular Sciences

Research output: Contribution to journal › Article › peer-review

109 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, and increases in prevalence with increasing age and the number of cardiovascular comorbidities. AF is characterized by a rapid and irregular heartbeat that can be asymptomatic or lead to symptoms such as palpitations, dyspnoea and dizziness. The condition can also be associated with serious complications, including an increased risk of stroke. Important recent developments in the clinical epidemiology and management of AF have informed our approach to this arrhythmia. This Primer provides a comprehensive overview of AF, including its epidemiology, mechanisms and pathophysiology, diagnosis, screening, prevention and management. Management strategies, including stroke prevention, rate control and rhythm control, are considered. We also address quality of life issues and provide an outlook on future developments and ongoing clinical trials in managing this common arrhythmia.

Original language	English
Article number	16016
Journal	Nature Reviews Disease Primers
Volume	2
DOIs	https://doi.org/10.1038/nrdp.2016.16
Publication status	Published - 31 Mar 2016

Access to Document

10.1038/nrdp.2016.16

Cite this

@article{99e543228c504e7f947540a5b720391f,

title = "Atrial fibrillation",

abstract = "Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, and increases in prevalence with increasing age and the number of cardiovascular comorbidities. AF is characterized by a rapid and irregular heartbeat that can be asymptomatic or lead to symptoms such as palpitations, dyspnoea and dizziness. The condition can also be associated with serious complications, including an increased risk of stroke. Important recent developments in the clinical epidemiology and management of AF have informed our approach to this arrhythmia. This Primer provides a comprehensive overview of AF, including its epidemiology, mechanisms and pathophysiology, diagnosis, screening, prevention and management. Management strategies, including stroke prevention, rate control and rhythm control, are considered. We also address quality of life issues and provide an outlook on future developments and ongoing clinical trials in managing this common arrhythmia.",

author = "Gregory Lip and Laurent Fauchier and Freedman, {S Ben} and {van Gelder}, Isabelle and Andrea Natale and Carola Gianni and Stanley Nattel and Potpara, {Tatjana S.} and Michel Rienstra and Tse, {Hung Fat} and Lane, {Deirdre A}",

year = "2016",

month = mar,

day = "31",

doi = "10.1038/nrdp.2016.16",

language = "English",

volume = "2",

journal = "Nature Reviews Disease Primers",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Atrial fibrillation

AU - Lip, Gregory

AU - Fauchier, Laurent

AU - Freedman, S Ben

AU - van Gelder, Isabelle

AU - Natale, Andrea

AU - Gianni, Carola

AU - Nattel, Stanley

AU - Potpara, Tatjana S.

AU - Rienstra, Michel

AU - Tse, Hung Fat

AU - Lane, Deirdre A

PY - 2016/3/31

Y1 - 2016/3/31

N2 - Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, and increases in prevalence with increasing age and the number of cardiovascular comorbidities. AF is characterized by a rapid and irregular heartbeat that can be asymptomatic or lead to symptoms such as palpitations, dyspnoea and dizziness. The condition can also be associated with serious complications, including an increased risk of stroke. Important recent developments in the clinical epidemiology and management of AF have informed our approach to this arrhythmia. This Primer provides a comprehensive overview of AF, including its epidemiology, mechanisms and pathophysiology, diagnosis, screening, prevention and management. Management strategies, including stroke prevention, rate control and rhythm control, are considered. We also address quality of life issues and provide an outlook on future developments and ongoing clinical trials in managing this common arrhythmia.

AB - Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, and increases in prevalence with increasing age and the number of cardiovascular comorbidities. AF is characterized by a rapid and irregular heartbeat that can be asymptomatic or lead to symptoms such as palpitations, dyspnoea and dizziness. The condition can also be associated with serious complications, including an increased risk of stroke. Important recent developments in the clinical epidemiology and management of AF have informed our approach to this arrhythmia. This Primer provides a comprehensive overview of AF, including its epidemiology, mechanisms and pathophysiology, diagnosis, screening, prevention and management. Management strategies, including stroke prevention, rate control and rhythm control, are considered. We also address quality of life issues and provide an outlook on future developments and ongoing clinical trials in managing this common arrhythmia.

U2 - 10.1038/nrdp.2016.16

DO - 10.1038/nrdp.2016.16

M3 - Article

VL - 2

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

M1 - 16016

ER -

Atrial fibrillation

Abstract

Access to Document

Fingerprint

Cite this